374 Exendin-4 has also been shown to stimulate osteoblast activity and mitigate bone loss in an ovariectomized mouse model
Below are general points to consider for each FDA-approved use
In plain English, that means it touches appetite, blood sugar, and how fast the body burns calories at the same time
P.DanielsG
Study selection The criteria for including studies in this meta-analysis were as follows: (1) (i) randomized controlled trials (RCTs) comparing different AOMs with placebo, including glucagon-like peptide 1 receptor agonist (GLP-1 RA), dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 RAs, GLP-1 and glucagon receptor (GCGR) dual-agonist, orlistat, lorcaserin, naltrexone-bupropion, phentermine-topiramate, and bimagrumab
Third, when retatrutide becomes available and you start seeing claims about it, the question to ask your doctor is not "does it work?" but "for my specific situation, what does it improve that we already know about, and what hasn't been studied yet?" Weight, blood-sugar control, and liver fat sit on strong evidence